triiodothyronine has been researched along with angiotensin i in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jiménez, E; Montiel, M; Morell, M; Narváez, JA | 2 |
| Inagami, T; Inui, H; Iwai, N; Kato, H; Kimoto, K; Uchiyama, Y | 1 |
| Barreto-Chaves, ML; da Silva, IB; Gomes, DA; Tavares, FM | 1 |
| Barreto-Chaves, MLM; Campagnole-Santos, MJ; Diniz, GP; Melo, MB; Santos, RAS; Senger, N | 1 |
| Akamine, EH; Barreto-Chaves, MLM; C Parletta, A; Campagnole-Santos, MJ; Diniz, GP; Marques, BVD; Santos, RAS; Senger, N | 1 |
6 other study(ies) available for triiodothyronine and angiotensin i
| Article | Year |
|---|---|
[Propranolol effect on renin-angiotensin system kinetics during experimental hyperthyroidism (author's transl)].
Topics: Angiotensin I; Animals; Hyperthyroidism; Kinetics; Male; Propranolol; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Thyroxine; Triiodothyronine | 1982 |
Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats.
Topics: Angiotensin I; Angiotensins; Animals; Hyperthyroidism; Hypothyroidism; Kinetics; Male; Propylthiouracil; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Thyroxine; Triiodothyronine | 1982 |
Regulation of vascular angiotensin release.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Aorta; Base Sequence; Biphenyl Compounds; Dexamethasone; Ethinyl Estradiol; Hindlimb; Imidazoles; Losartan; Male; Molecular Sequence Data; Muscle, Smooth, Vascular; Muscles; Nephrectomy; Oligodeoxyribonucleotides; Perfusion; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles; Triiodothyronine | 1993 |
Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.
Topics: AMP-Activated Protein Kinases; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiomegaly; Hyperthyroidism; Imidazoles; Male; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thyroxine; Triiodothyronine; Ventricular Pressure | 2013 |
Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway.
Topics: Angiotensin I; Animals; Cardiomegaly; Cells, Cultured; Echocardiography; Glycogen Synthase Kinase 3 beta; Hyperthyroidism; Male; Myocytes, Cardiac; NFATC Transcription Factors; Peptide Fragments; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Triiodothyronine | 2018 |
Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB.
Topics: Angiotensin I; Animals; Antioxidants; Catalase; Down-Regulation; Forkhead Box Protein O3; Hypertrophy; Male; Models, Biological; Myocytes, Cardiac; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Superoxide Dismutase-1; Triiodothyronine; Up-Regulation | 2021 |